David C. Dreyer, SVP / Chief Financial Officer at BIOLASE, INC (BIOL), bought 33,000 shares at $0.77 ($25K) on 2015-11-09, disclosed to the SEC on 2015-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| INFU | SELL | 2018-06-26 | $156K | — | Filing → |
| INFU | SELL | 2018-06-15 | $655K | — | Filing → |
| BIOL | BUY | 2015-09-25 | $6K | — | Filing → |